sulfacetamide sodium and sulfur Sodium Sulfacetamide - Sulfur
NDC 28595-501, sulfacetamide sodium and sulfur, suspension, from Allegis Pharmaceuticals, LLC.
- Product NDC
- 28595-501
- Status
- Listed
- Labeler
- Allegis Pharmaceuticals, LLC
- Dosage form
- SUSPENSION
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/28595-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SULFACETAMIDE SODIUM90 mg/mL
- SULFUR42.5 mg/mL
Pharmacologic classes
Sulfonamide Antibacterial [EPC]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 28595-501-08 | 28595050108 | 237 mL in 1 BOTTLE (28595-501-08) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1aa1025f-c568-34d3-e063-6394a90a37b8
Use it
Look up 28595-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/28595-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 28595-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.